İntravenöz Deksmedetomidinin Spinal Blok ve Sedasyon Üzerine Etkisi

Cilt: 40 Sayı: 1 9 Eylül 2015
Abdurrahman Ekici , Mediha Türktan , Tayfun Güler
PDF İndir
EN TR

The Effect of Intravenous Dexmedetomidine on Spinal Block and Sedation

Abstract

Purpose: Spinal anesthesia is often preferred anesthesia technique in urological surgery. Some patients may require sedation during spinal anesthesia. In our study, we aimed to investigate the effect of intravenous dexmedetomidine on sedation, motor and sensory blockade under spinal anesthesia with levobupivacaine. Material and Methods: Our randomised, double-blind study was applied to ASA I-III, 18-75 years old 50 patients scheduled for transurethral surgery. The patients were divided into two groups and spinal anesthesia with 5% levobupivacaine 12.5 mg was administered to all patients. Intravenous dexmedetomidine was received 1 µg/kg for loading dose before 0.5 µg/kg/hour infusion to Group D (n=25). Saline infusion was given to Group S (n=25) as the same volume and infusion rate of dexmedetomidine. Systolic, diastolic and mean arterial pressure, heart rate, peripheral oxygen saturation values, pain and sedation score, the level and duration of motor and sensorial block, recovery and patient comfort score and side effects were recorded. Results: Time to reach maximum block level and duration of spinal anesthesia were longer in Group D than Group S. Sedation scores were significantly higher in Group D than Group S intraoperatively (except 1th minute) and Araştırma Makalesi / Research Article 55 Ekici ve ark. Cukurova Medical Journal postoperatively 10th and 15th minutes. The incidence of side effects, postoperative recovery and patient comfort values were similar between the groups. Conclusion: We found that dexmedetomidine prolongs duration of motor block, provides safe and effective sedation without increasing the incidence of side effect in the patients under spinal anesthesia.

Keywords

Spinal anesthesia, transurethral surgery, dexmedetomidine, sedation

Kaynakça

  1. .Brown DL. Spinal, epidural and caudal anesthesia. In: Miller RD, editor. Anesthesia. Philadelphia: Churchill-Livingstone; 2000;1492–8.
  2. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–33.
  3. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705. Intrathecal Dexmedetomidine on Low-Dose Bupivacaine Spinal Anesthesia in Elderly Patients Undergoing Transurethral Prostatectomy. Biol. Pharm. Bull. 2013;36:959– 65.
  4. McVey JD, Tobias JD. Dexmedetomidine and ketamine for sedation during spinal anesthesia in children. Journal of Clinical Anesthesia. 2010;22:538–45.
  5. Hong JY, Kim WO, Yoon Y, Choi Y, Kim SH, Kil HK. Effects of intravenous dexmedetomidine on low-dose bupivacaine spinal anaesthesia in elderly patients. Acta Anaesthesiol Scand. 2012;56:382–7.
  6. Elcicek K, Tekin M, Kati I. The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anesthesia. J Anesth. 2010;24:544–8
  7. Kanazi GE, Aouad MT, Jabbour-Khoury SI. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anesthesiol Second. 2006;50: 222-7.
  8. Kaya FN, Yavaşçaoğlu B, Turker G, Yıldırım A, Gurbet A, Moğol EB, Özcan B. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth. 2010;57:39-45.
  9. Rhee K, Kang K, Kim J, Jeon Y. Intravenous clonidine prolongs bupivacaine spinal anesthesia.
  10. Acta Anaesthesiol Scand. 2003;47:1001–5.

Kaynak Göster

MLA
Ekici, Abdurrahman, vd. “The Effect of Intravenous Dexmedetomidine on Spinal Block and Sedation”. Cukurova Medical Journal, c. 40, sy 1, Eylül 2015, ss. 55-62, doi:10.17826/cutf.00244.